A Review on Patients with Tricuspid Regurgitation: Pathophysiology, Investigations, and Treatment
Omar Elsaka *
Department of Cardiology, Mansoura University, Faculty of Medicine, Mansoura Manchester Medical Program (MMMP), Mansoura, Egypt.
Moneer Ayman Noureldean
Department of Cardiology, Mansoura University, Faculty of Medicine, Mansoura Manchester Medical Program (MMMP), Mansoura, Egypt.
Mohamed Adel Gamil
Department of Cardiology, Mansoura University, Faculty of Medicine, Mansoura Manchester Medical Program (MMMP), Mansoura, Egypt.
Mostafa Tarek Ghazali
Department of Cardiology, Mansoura University, Faculty of Medicine, Mansoura Manchester Medical Program (MMMP), Mansoura, Egypt.
Ashraf Hamada Abd Al-Razik
Department of Cardiology, Mansoura University, Faculty of Medicine, Mansoura Manchester Medical Program (MMMP), Mansoura, Egypt.
Dalia Hisham
Department of Cardiology, Mansoura University, Faculty of Medicine, Mansoura Manchester Medical Program (MMMP), Mansoura, Egypt.
*Author to whom correspondence should be addressed.
Abstract
Background: Tricuspid insufficiency, also known as tricuspid regurgitation, is a reasonably common disorder caused by anatomical anomalies in any portion of the tricuspid valve mechanism. Modifications to the valve leaflets, annulus, chordae tendineae, or papillary muscles may be required. This activity examines the diagnosis and treatment of tricuspid regurgitation, emphasizing the importance of interprofessional team members working together to deliver well-coordinated care and improve patient outcomes.
Conclusion: The purpose of this review article is to describe the anatomy of the tricuspid valve and how it is affected by insufficiency, to recall the causes of tricuspid insufficiency, to summarise the treatment options for tricuspid insufficiency, and to look at the importance of improving care coordination among interprofessional team members to improve outcomes for patients with tricuspid insufficiency.
Keywords: Chromosomes, Cardiac surgery, Noctuidae, tricuspid regurgitation, Modal Number, valvular heart disease, cardiac magnetic resonance, computed tomography angiography, echocardiography
How to Cite
Downloads
References
Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012; 33(19):2451-96.
Anderson C, Filsoufi F, Farivar RS, Adams DH. Optimal management of severe tricuspid regurgitation in cardiac transplant recipients. J Heart Lung Transplant. 2001;20(2):247.
Campelo-Parada F, Perlman G, Philippon F, et al. First-in-man experience of a novel transcatheter repair system for treating severe tricuspid regurgitation. J Am Coll Cardiol. 2015;66(22):2475-83.
DeLeon MA, Gidding SS, Gotteiner N, Backer CL, Mavroudis C. Successful palliation of Ebstein's malformation on the first day of life following fetal diagnosis. Cardiol Young. 2000;10(4):384-7.
Filsoufi F, Anyanwu AC, Salzberg SP, et al. Long-term outcomes of tricuspid valve replacement in the current era. Ann Thorac Surg. 2005;80(3):845-50.
Frater R. Tricuspid insufficiency. J Thorac Cardiovasc Surg. 2001;122(3):427-9.
Gatti G, Maffei G, Lusa AM, Pugliese P. Tricuspid valve repair with the Cosgrove-Edwards annuloplasty system: Early clinical and echocardiographic results. Ann Thorac Surg. 2001;72(3):764-7.
Ha JW, Chung N, Jang Y, Rim SJ. Tricuspid stenosis and regurgitation: Doppler and color flow echocardiography and cardiac catheterization findings. Clin Cardiol. 2000;23(1):51-2.
Ibrahim M, Tsang VT, Caruana M, et al. Cone reconstruction for Ebstein's anomaly: Patient outcomes, biventricular function, and cardiopulmonary exercise capacity. J Thorac Cardiovasc Surg. 2015;149(4): 1144-50.
Khan IA. Ebstein's anomaly of the tricuspid valve with associated mitral valve prolapse. Tex Heart Inst J. 2001;28(1):72.
Luo GH, Ma WG, Sun HS, et al. Correction of traumatic tricuspid insufficiency using the double orifice technique. Asian Cardiovasc Thorac Ann. 2005;13(3):238-40.
Roberts PA, Boudjemline Y, Cheatham JP, et al. Percutaneous tricuspid valve replacement in congenital and acquired heart disease. J Am Coll Cardiol. 2011;58(2):117-22.
Shah PM, Raney AA. Tricuspid valve disease. Curr Probl Cardiol. 2008;33(2):47-84.
Simula DV, Edwards WD, Tazelaar HD, et al. Surgical pathology of carcinoid heart disease: A study of 139 valves from 75 patients spanning 20 years. Mayo Clin Proc. 2002;77(2):139-47.
Sugimoto T, Okada M, Ozaki N, et al. Long-term evaluation of treatment for functional tricuspid regurgitation with regurgitant volume: Characteristic differences based on primary cardiac lesion. J Thorac Cardiovasc Surg. 1999; 117(3):463-71.
Takagi H, Hari Y, Kawai N, Ando T, ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Impact of concurrent tricuspid regurgitation on mortality after transcatheter aortic-valve implantation. Catheter Cardiovasc Interv. 2019;93(5):946-53.
Topilsky Y, Khanna AD, Oh JK, et al. Preoperative factors associated with adverse outcome after tricuspid valve replacement. Circulation. 2011;123(18):1929-39.
Topilsky Y, Tribouilloy C, Michelena HI, Pislaru S, Mahoney DW, Enriquez-Sarano M. Pathophysiology of tricuspid regurgitation: Quantitative Doppler echocardiographic assessment of respiratory dependence. Circulation. 2010; 122(15):1505-13.
Vlahos AP, Feinstein JA, Schiller NB, Silverman NH. Extension of Doppler-derived echocardiographic measures of pulmonary vascular resistance to patients with moderate or severe pulmonary vascular disease. J Am Soc Echocardiogr. 2008;21(6):711-4.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: Executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35-e71.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72-e227.
Nishimura RA, Otto CM, Bonow RO, et al, for the ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):e521-643.
Yang WI, Shim CY, Kang MK, et al. Vena contracta width as a predictor of adverse outcomes in patients with severe isolated tricuspid regurgitation. J Am Soc Echocardiogr. 2011;24(9):1013-9.